• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

172.16 +0.30 (+0.17%)
Official Closing Price Updated: 4:15 PM EDT, Apr 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 796,146
Open 171.41
Bid (Size) 170.73 (1,800)
Ask (Size) 172.62 (600)
Prev. Close 171.86
Today's Range 170.33 - 172.62
52wk Range 107.43 - 179.64
Shares Outstanding N/A
Dividend Yield 0.21%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally
March 31, 2026
In a month characterized by macroeconomic headwinds and a broader cooling of the biotechnology sector, Corcept Therapeutics (NASDAQ: CORT) has emerged as a definitive outlier. While the S&P Biotech ETF... 
Via MarketMinute
Topics ETFs Intellectual Property Stocks
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
March 21, 2026
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but... 
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance

Performance

YTD
+1.9%
+1.9%
1 Month
+0.5%
+0.5%
3 Month
-2.6%
-2.6%
6 Month
+13.3%
+13.3%
1 Year
+53.7%
+53.7%

More News

Read More
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
March 10, 2026
Via Stocktwits
Topics Initial Public Offering
PLRZ Stock Jumps 6% In Pre-Market – Why Is This Biotech Firm Diversifying Into Aviation Business? ↗
February 10, 2026
Via Stocktwits
News headline image
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 ↗
March 09, 2026
Via Stocktwits
News headline image
Why Did CRMD Stock Tumble Over 11% Today? ↗
March 05, 2026
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
March 05, 2026
Via Stocktwits
News headline image
Why Did CDXS Stock Jump 7% Today? ↗
March 04, 2026
Via Stocktwits
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
March 02, 2026
Via Stocktwits
News headline image
AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates ↗
February 26, 2026
Via Stocktwits
News headline image
VIR Stock Surges 60% Pre-Market Today – Analysts Cheer Strong Cancer Data, Astellas Partnership ↗
February 24, 2026
Via Stocktwits
News headline image
ImmunityBio’s Q4 Revenue Gets A Lift From ANKTIVA Sales – IBRX Stock Gains 1% Pre-Market ↗
February 23, 2026
Via Stocktwits
News headline image
Why Did ACLX Stock Surge 80% In Pre-Market Today? ↗
February 23, 2026
Via Stocktwits
News headline image
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition ↗
February 18, 2026
Via Stocktwits
News headline image
CMPS Stock Rises 23% Pre-Market As Compass Achieves Primary Endpoint In Phase 3 Treatment-Resistant Depression Trial ↗
February 17, 2026
Via Stocktwits
News headline image
CMPS Stock Jumps 22% Pre-Market As Compass Sets Timeline For New Phase 3 Depression Trial Results ↗
February 17, 2026
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
February 09, 2026
Via Stocktwits
News headline image
Why Is ALVO Stock Rising Pre-Market Today? ↗
February 05, 2026
Via Stocktwits
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock ↗
January 30, 2026
Via Stocktwits
News headline image
Why Did SER Stock Surge Over 70% In Pre-Market Today? ↗
January 29, 2026
Via Stocktwits
News headline image
This Wealth Manager Just Dumped Its Entire $3.5 Million Stake in the iShares Biotech ETF ↗
January 27, 2026
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
January 24, 2026
Via The Motley Fool
Topics ETFs Intellectual Property World Trade
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
January 23, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 172.16
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 04/09/26 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap